Dernek Hakkında Tıbbi Onkoloji Derneği Haberler

Annals of Oncology - Ağustos 2010


Investigator-initiated trials of targeted oncology agents: why independent research is at risk? 
L. Bergmann,  B. Berns,  A. G. Dalgleish,  M. von Euler,  T. T. Hecht,  G. L. Lappin,  N. Reed,  S. Palmeri,  J. Smyth,  S. Embacher-Aichorn,  H. Zwierzina,  and Biotherapy Development Association 

Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer—an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009 

Original Articles

Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study 

Phase II trial of neoadjuvant temozolomide in resectable melanoma patients 
G. D. Shah,  N. D. Socci,  J. S. Gold,  J. D. Wolchok,  R. D. Carvajal,  K. S. Panageas,  A. Viale,  M. S. Brady,  D. G. Coit,  and P. B. Chapman